Takeda Pharmaceutical Co Ltd (HAM:TKD)
€ 25.5 -0.16 (-0.62%) Market Cap: 41.10 Bil Enterprise Value: 67.01 Bil PE Ratio: 22.79 PB Ratio: 0.95 GF Score: 75/100

Takeda Pharmaceutical Co Ltd QDENGA Investor Call Transcript

Mar 15, 2023 / 11:00PM GMT
Release Date Price: €29.84 (+1.53%)
Elizabeth Borgeson
Takeda Pharmaceutical Company Limited - Executive of IR

Good morning, good evening, everyone. This is Elizabeth Borgeson. As part of the IR team at Takeda, I'd like to welcome you to our event, where we will be discussing our new dengue vaccine QDENGA. (Operator Instructions)

Moving to Slide 2. I'd like to remind everyone that I'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Also refer to the important notice on Slide 2 of the presentation.

We have a great presentation for you today. So without further ado, let me introduce Ramona Sequeira, President of Global Portfolio division. Ramona, I'll hand it over to you to introduce the rest of the team.

Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division

Thank you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot